Preventing inflammation inhibits biopsy-mediated changes in tumor cell behavior

Publication date

2017-12-01

Authors

Alieva, Maria
Margarido, Andreia S.
Wieles, Tamara
Abels, Erik R.
Colak, Burcin
Boquetale, Carla
Noordmans, Herke-JanORCID 0000-0002-9913-4556ISNI 0000000397040801
Snijders, T. J.ORCID 0000-0003-0857-081XISNI 000000039373112X
Broekman, MariekeISNI 0000000394030739
van Rheenen, JaccoISNI 0000000389238762

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

Abstract

Although biopsies and tumor resection are prognostically beneficial for glioblastomas (GBM), potential negative effects have also been suggested. Here, using retrospective study of patients and intravital imaging of mice, we identify some of these negative aspects, including stimulation of proliferation and migration of non-resected tumor cells, and provide a strategy to prevent these adverse effects. By repeated high-resolution intravital microscopy, we show that biopsy-like injury in GBM induces migration and proliferation of tumor cells through chemokine (C-C motif) ligand 2 (CCL-2)-dependent recruitment of macrophages. Blocking macrophage recruitment or administrating dexamethasone, a commonly used glucocorticoid to prevent brain edema in GBM patients, suppressed the observed inflammatory response and subsequent tumor growth upon biopsy both in mice and in multifocal GBM patients. Taken together, our study suggests that inhibiting CCL-2-dependent recruitment of macrophages may further increase the clinical benefits from surgical and biopsy procedures.

Keywords

Cancer imaging, CNS cancer, General

Citation

Alieva, M, Margarido, A S, Wieles, T, Abels, E R, Colak, B, Boquetale, C, Jan Noordmans, H, Snijders, T J, Broekman, M L & Van Rheenen, J 2017, 'Preventing inflammation inhibits biopsy-mediated changes in tumor cell behavior', Scientific Reports, vol. 7, 7529. https://doi.org/10.1038/s41598-017-07660-4